Healthcare News and Research

Latest Healthcare News and Research

Rate of weight gain, not the degree of fatness at any one time, which is the main predictor of future problems

Research published today indicates that the risk of heart disease in adulthood is more strongly related to how quickly children gain weight between the ages of two and eleven than their actual body weight at any particular age. Scientists believe this is linked to differences in insulin processing in later life.

27 Oct 2005

Unique report on global long-term care worker migration

Who will provide long-term care to you or your loved ones? If you live in developed countries like the US or the UK, the answer may surprise you according to a new report issued by the AARP Public Policy Institute.

26 Oct 2005

25 years down the line, 1800 children daily infected with AIDS

The UN charity UNICEF, has launched a global campaign to highlight the impact on children of AIDS.

26 Oct 2005

State budget cuts lead to decline in care by private practice physicians

In a study of access to specialty healthcare by the uninsured and publicly insured in New Haven, Yale researchers found that recent state budget cuts, out-of-date provider rates and other policy changes had caused a decline in care by private practice physicians.

25 Oct 2005

Two competing drug-eluting stents work equally well

After completing the most comprehensive U.S.-based study of its kind, Dr. Charles Simonton reported that the performance of two competing coronary stents was "virtually identical" in head-to-head comparisons.

25 Oct 2005

Depression raises disability risk

Depressed middle-aged adults are at four times greater risk for being unable to perform everyday tasks than their non-depressed peers, a Northwestern University study found.

25 Oct 2005

NHS needs an independent regulator

The NHS should have an independent regulator like other public utilities in the UK, argues a senior doctor in this week’s British Medical Journal.

20 Oct 2005

EU influenza pandemic preparedness

EU preparedness against an influenza pandemic has improved over the last six months, but Member States need to step up their efforts to strengthen their pandemic preparedness, according to Markos Kyprianou, European Commissioner for Health and Consumer Protection.

19 Oct 2005

Distress caused by hot flushes seriously under-played

A study by UK researchers of over 200 breast cancer patients receiving hormone treatments such as tamoxifen has found that nearly two-thirds would prefer to take a tablet daily and around a quarter would prefer a monthly injection, given that both treatments would be equally effective and have similar side-effects.

19 Oct 2005

Health insurers are turning to a new approach to get doctors and hospitals to do better

In this approach, insurers offer financial rewards for better or more efficient care and sometimes create penalties for poor performance. Even though it has become commonplace, there is little evidence about its impact on care, says R. Adams Dudley, MD, MBA, a professor in the UCSF Institute for Health Policy Studies and the Department of Medicine.

18 Oct 2005

Bayer to produce new Tuberculosis drug at low prices for poor nations

A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.

18 Oct 2005

Antibiotic moxifloxacin as a new treatment for tuberculosis

Moxifloxacin is currently approved in more than 100 countries, including the United States, as a treatment for bacterial respiratory infections, such as bronchitis, sinusitis and pneumonia.

17 Oct 2005

Scottish hospitals to issue 'red cards' to violent patients

Medical staff in hospitals and health clinics in Glasgow, Scotland, have been given the power to refuse to treat patients who submit them to physical or verbal attacks.

17 Oct 2005

Isotretinoin-related birth defects

Isotretinoin (also known as Accutane) is a drug used to treat severe acne, but it can cause birth defects when taken by pregnant women. Because of these risks, the U.S. Food and Drug Administration and Roche Pharmaceuticals (Accutane's manufacturer) developed a voluntary pregnancy prevention program (PPP) in 1988 to try and prevent conception in women taking the drug.

16 Oct 2005

Why breast black cancer patients experience lower survival rates than other women

Black women with stage I or II breast cancer are more likely than their counterparts of other races to abandon chemotherapy before completing their full course of treatment, according to a recent Columbia University Medical Center study.

12 Oct 2005

Researchers call for better recognition and pain management of endometriosis

Women with endometriosis can wait up to ten years for the painful gynaecological condition to be diagnosed, according to a paper in latest issue of UK-based Journal of Clinical Nursing.

12 Oct 2005

Long-term smoking linked to diminished mental proficiency

The association between long-term smoking and diminished mental proficiency in 172 alcoholic and non-alcoholic men was a surprising finding from a study that set out to examine alcoholism's long-term effect on the brain and thinking skills.

11 Oct 2005

Study confirms that couples using natural family planning have intercourse just as frequently as couples using other methods

Couples who use fertility awareness-based methods of family planning have sex just as often as couples who use other contraceptive methods -- they just time it differently, according to a new Georgetown University Institute for Reproductive Health study to be published in a forthcoming edition of the Journal of Biosocial Science.

11 Oct 2005

Third Wave Technologies files patent suits against Chiron and Bayer

The company last Friday filed suit against Digene Corp., seeking a court ruling supporting Third Wave's right to sell its human papilloma virus (HPV) products. Third Wave today also filed suit against Chiron Corp., Bayer Corp., and Bayer HealthCare LLC asking for a similar ruling about its right to sell its hepatitis C virus products.

11 Oct 2005

Nabi Biopharmaceuticals granted Staphylococcus Antigen and Vaccine patent

Nabi Biopharmaceuticals has announced that it has been granted U.S. Patent No. 6,936,258 entitled "Staphylococcus Antigen and Vaccine" by the U.S. Patent and Trademark Office for the composition of a strategically important glycoprotein-based antigen (GP-1) associated with three Staphylococcal strains: S. epidermidis, S. haemolyticus and S. hominis.

11 Oct 2005